These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19397797)

  • 21. Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy.
    Gbotosho GO; Happi CT; Ganiyu A; Ogundahunsi OA; Sowunmi A; Oduola AM
    Malar J; 2009 Dec; 8():313. PubMed ID: 20042098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use.
    Noranate N; Durand R; Tall A; Marrama L; Spiegel A; Sokhna C; Pradines B; Cojean S; Guillotte M; Bischoff E; Ekala MT; Bouchier C; Fandeur T; Ariey F; Patarapotikul J; Le Bras J; Trape JF; Rogier C; Mercereau-Puijalon O
    PLoS One; 2007 Jan; 2(1):e139. PubMed ID: 17206274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
    Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
    J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of malaria mortality and morbidity after the emergence of chloroquine resistance in Niakhar, Senegal.
    Munier A; Diallo A; Marra A; Cot M; Arduin P; Ndiaye O; Mboup BM; Gning B; Chippaux JP
    Malar J; 2009 Nov; 8():270. PubMed ID: 19943921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal.
    Agnamey P; Brasseur P; Cisse M; Gaye O; Dumoulin J; Rigal J; Taylor WR; Olliaro P
    Trop Med Int Health; 2005 Sep; 10(9):926-33. PubMed ID: 16135201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
    Hombhanje FW; Linge D; Saweri A; Kuanch C; Jones R; Toraso S; Geita J; Masta A; Kevau I; Hiawalyer G; Sapuri M
    Malar J; 2009 Aug; 8():196. PubMed ID: 19671190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine.
    Sokhna CS; Trape JF; Robert V
    Parasite; 2001 Sep; 8(3):243-50. PubMed ID: 11584755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
    Nsimba SE
    J Ethnobiol Ethnomed; 2006 Jan; 2():5. PubMed ID: 16403225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia.
    Osorio LE; Giraldo LE; Grajales LF; Arriaga AL; Andrade AL; Ruebush TK; Barat LM
    Am J Trop Med Hyg; 1999 Dec; 61(6):968-72. PubMed ID: 10674680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos.
    Schwöbel B; Jordan S; Vanisaveth V; Phetsouvanh R; Christophel EM; Phompida S; von Sonnenburg F; Jelinek T
    Trop Med Int Health; 2003 Jan; 8(1):19-24. PubMed ID: 12535245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
    Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.
    Abacassamo F; Enosse S; Aponte JJ; Gómez-Olivé FX; Quintó L; Mabunda S; Barreto A; Magnussen P; Rønn AM; Thompson R; Alonso PL
    Trop Med Int Health; 2004 Feb; 9(2):200-8. PubMed ID: 15040556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
    Diawara S; Madamet M; Kounta MB; Lo G; Wade KA; Nakoulima A; Bercion R; Amalvict R; Gueye MW; Fall B; Diatta B; Pradines B
    Malar J; 2017 Mar; 16(1):118. PubMed ID: 28302108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
    Mbacham WF; Evehe MS; Netongo PM; Ateh IA; Mimche PN; Ajua A; Nji AM; Irenee D; Echouffo-Tcheugui JB; Tawe B; Hallett R; Roper C; Targett G; Greenwood B
    Malar J; 2010 Jan; 9():34. PubMed ID: 20105282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in PFCRT K76T do not correlate with sulfadoxine-pyrimethamine-amodiaquine failure in Pikine, Senegal.
    Sarr O; Ahouidi AD; Ly O; Daily JP; Ndiaye D; Ndir O; Mboup S; Wirth DF
    Parasitol Res; 2008 Sep; 103(4):765-9. PubMed ID: 18523801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
    Oduro AR; Anyorigiya T; Hodgson A; Ansah P; Anto F; Ansah NA; Atuguba F; Mumuni G; Amankwa J
    Trop Med Int Health; 2005 Mar; 10(3):279-84. PubMed ID: 15730512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.